Transplantation-mediated alloimmune thrombocytopenia: Guidelines for utilization of thrombocytopenic donors

Liver Transplantation

Volumn 14, Issue 12, 2008, Pages 1803-1809

  Diaz, Geraldine C ^a   Prowda, Joan ^b   Lo, Irene J ^c   Arepally, Gowthami M ^d   Evans, Neal ^e   Wheeless, Yvonne ^e   Samstein, Benjamin ^c   Guarrera, James V ^c   Renz, John F ^f  

^a UNIVERSITY OF ARIZONA   (United States)

^b Department of Radiology ^*  (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e Carolina Donor Services   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; AMLODIPINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; IMMUNOGLOBULIN; INTERFERON; LAMIVUDINE; METHYLPREDNISOLONE; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VINCRISTINE;

ADULT; ALLOIMMUNE THROMBOCYTOPENIA; CADAVER DONOR; CASE REPORT; CRYOGLOBULINEMIA; DONOR SELECTION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOSCOPY; EPISTAXIS; HEALTH CARE UTILIZATION; HEMATOCHEZIA; HEMODIALYSIS; HUMAN; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; KIDNEY FAILURE; KIDNEY FUNCTION; LAPAROTOMY; LIVER FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MELENA; MUCOSAL BLEEDING; PATIENT INFORMATION; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SPLENECTOMY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; AGED; CADAVER; DONOR; HEMATOMA; HEPATITIS C; IMMUNOLOGY; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; RADIOGRAPHY; VIROLOGY;

AGED; CADAVER; HEMATOMA; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; THROMBOCYTOPENIA; TISSUE DONORS;

EID: 58249088516     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21539     Document Type: Review

References (52)

1. Friend PJ, McCarthy LJ, Filo RS, Leapman SB, Pescovitz MD, Lumeng L, et al. Transmission of idiopathic (autoimmune) thrombocytopenic purpura by liver transplantation. N Engl J Med 1990;323:807-811.
2. Takatsuki M, Uemoto T, Kurokawa T, Koshiba T, Inomata Y, Tanaka K. Idiopathic thrombocytopenic purpura after a living-related liver transplantation. Transplantation 1999; 67:479-481.
3. De La Torre AN, Fisher A, Wilson DJ, Harrison J, Koneru B. A case report of donor to recipient transmission of severe thrombocytopenic purpura. Transplantation 2004; 77:1473-1474.
4. Aster R. The immunologic thrombocytopenias. In: Kunicki T, George J, eds. Platelet Immunobiology: Molecular and Clinical Aspects. Philadelphia, PA: Lippincott; 1989:387-435.
5. van Leeuwen EF, van der Ven JT, Engelfriet CP, von dem Borne AE. Specificity of autoantibodies in autoimmune thrombocytopenia. Blood 1982;59:23-26.
6. Woods VL Jr, Kurata Y, Montgomery RR, Tani P, Mason D, Of EH, McMillan R. Autoantibodies against platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood 1984;63:368-375.
7. Beardsley DS, Spiegel JE, Jacobs MM, Handin RI, Lux SE IV. Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias. J Clin Invest 1984;74:1701-1707.
8. West KA, Anderson DR, McAlister VC, Hewlett TJC, Belitsky P, Smith JW, Kelton JG. Alloimmune thrombocytopenia after organ transplantation. N Engl J Med 1999;341: 1504-1507.
9. Visentin GP, Newman PJ, Aster RH. Characteristics of quinene- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa. Blood 1991;77:2668-2776.
10. Asvadi P, Ahmadi Z, Chong BH. Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies. Blood 2003;102:1670-1677.
11. Garner SF, Campbell K, Metcalfe P, Keidan J, Huiskes E, Dong JF, et al. Glycoprotein V: the predominant target antigen in gold-induced autoimmune thrombocytopenia. Blood 2002;100:344-346.
12. Warkentin TE. Drug-induced immune-mediated thrombocytopenia - from purpura to thrombosis. N Engl J Med 2007;356:891-893.
13. Troisi R, Hesse UJ, Decuyenaere J, Morelli MC, Palazzo U, Pattyn P, et al. Functional, life-threatening disorders and splenectomy following liver transplantation. Clin Transplant 1999;13:380-388.
14. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008.
15. Chong BH, Ho SJ. Autoimmune thrombocytopenia. J Thromb Haemost 2005;3:1763-1772.
16. Taylor RM, Bockenstedt P, Su GL, Marrero JA, Pellitier SM, Fontana RJ. Immune thrombocytopenic purpura following liver transplantation: a case series and review of the literature. Liver Transpl 2006;12:781-791.
17. Bussel J. Overview of idiopathic thrombocytopenic purpura: new approach to refractory patients. Semin Oncol 2000;27(suppl 12):91-98.
18. Aster R. Drug-induced thrombocytopenia. In: Michelson A, ed. Platelets. New York, NY: Academic Press; 2007:887-902.
19. Aster RH. Drug-induced immune cytopenias. Toxicology 2005;209:149-153.
20. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children, and in pregnancy. Br J Haematol 2003;120:574-596.
21. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med 2007;357:580-587.
22. Kajihara M, Kato S, Okazaki Y, Kawakami Y, Ishii H, Ikeda Y, Kuwana M. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. Hepatology 2003;37:1267-1276.
23. Newland A. Idiopathic thrombocytopenic purpura and IgG: a review. J Infect 1987;15(suppl 1):41-49.
24. Szatkowski N, Aster RH. Idiopathic (autoimmune) thrombocytopenic purpura with complement-fixing autoantibody and response to plasma exchange. Scand J Haematol 1985;35:525-530.
25. Marder VJ, Nusbacher J, Anderson FW. One-year follow-up of plasma exchange therapy in 14 patients with idiopathic thrombocytopenic purpura. Transfusion 1981; 21:291-298.
26. Narang M, Penner JA, Williams D. Refractory autoimmune thrombocytopenic purpura: responses to treatment with a recombinant antibody to lymphocyte membrane antigen CD20 (rituximab). Am J Hematol 2003;74:263-267.
27. Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases. Am J Hematol 2005;78:49-54.
28. Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, et al. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura. Am J Hematol 2005;78:275-280.
29. Chatzipetrou MA, Tsaroucha AK, Weppler D, Pappas PA, Kenyon NS, Nery JR, et al. Thrombocytopenia after liver transplantation. Transplantation 1999;67:702-706.
30. Chang FY, Singh N, Gayowski T, Wagener MM, Mietzner SM, Stout JE, Marino IR. Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation 2000;69:69-70.
31. Rosoff PM, Tuttle-Newhall E, Treem WR. Successful treatment of immune thrombocytopenic purpura with anti-D antibody following a cadaveric liver transplant for hepatoblastoma. Med Pediatr Oncol 2003;40:402-404.
32. Assy N, Rosenthal E, Hazani A, Etzioni A, Baruch Y. Human parvovirus B19 infection associated with idiopathic thrombocytopenic purpura in a child following liver transplantation. J Hepatol 1997;27:934-936.
33. Randoux O, Gambiez L, Navarro F, Declerck N, Labalette M, Dessaint JP, Pruvot FR. Post-liver transplantation thrombocytopenia: a persistent immunologic sequestration? Transplant Proc 1995;27:1710-1711.
34. Plevak DJ, Halma GA, Forstrom LA, Dewanjee MK, O'Connor MK, Moore SB, et al. Thrombocytopenia after liver transplantation. Transplant Proc 1988;20:630-633.
35. Gregoire J. Immune hemolytic anemia after renal transplantation secondary to ABO-minor-mismatch between the donor and recipient. J Am Soc Nephrol 1993;4:1122-1126.
36. Nijjar TS, Bonacosa I, Israels LG. Severe acute thrombocytopenia following infusion of plasma containing AntiP1A1. Am J Hematol 1987;25:219-221.
37. Ballem PJ, Buskard NA, Decary F, Doubroff P. Post-transfusion purpura secondary to passive transfer of anti-P1A1 by blood transfusion. Br J Haematol 1987;66:113-114.
38. Tredger J, Brown NW, Adams J, Gonde CE, Dhawan A, Rela M, Heaton N. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl 2004;10:492-502.
39. Danesi R, Del Tacca M. Hematologic toxicity of immunosuppressive treatment. Transplant Proc 2004;36:703-704.
40. Rerolle J, Akposso K, Lerolle N, Mougenot B, Ponnelle T, Rondeau E, Sraer JD. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation. Clin Transplant 2000;14:262-265.
41. Singh N, Gayowski T, Marino I. Hemolytic uremic syndrome in solid-organ transplant recipients. Transpl Int 1996;9:68-75.
42. Abraham KA, Little MA, Dorman AM, Walshe JJ. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus. Transpl Int 2000;13:443-447.
43. Scaradavou A. HIV-related thrombocytopenia. Blood Rev 2002;16:73-76.
44. Singh N, Gayowski T, Yu VL. Herpes zoster-associated idiopathic thrombocytopenic purpura in a liver transplant recipient: a case report and overview. Transpl Int 1995;8:58-60.
45. Arnold JC, Heilig B, Otto G, Kommerell B, Theilmann L. Cytomegalovirus-induced severe thrombocytopenia after liver transplantation. Transplantation 1993;56:1286-1288.
46. Kita Y, Harihara Y, Hirata M, Sano K, Kubota K, Takayama T, et al. Splenectomy for idiopathic thrombocytopenic purpura after living-related liver transplantation. Transplantation 2000;70:553-555.
47. Pockros PJ, Duchini A, McMillan R, Nyberg LM, McHutchison J, Viernes E. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2002;97:2040-2045.
48. Bauduer F, Marty F, Larrouy M, Ducout L. Immunologic thrombocytopenic purpura as presenting symptom of hepatitis C infection. Am J Hematol 1998;57:338-340.
49. Pawlotsky J, Bouvier M, Fromont P, Deforges L, Duval J, Dhumeaux D, Bierling P. Hepatitis C virus infection and autoimmune thrombocytopenic purpura. J Hepatol 1995; 23:635-639.
50. Shulman N. Post-transfusion purpura due to a complement fixing antibody against a genetically controlled platelet antigen. A proposed mechanism for thrombocytopenia and its relevance in "autoimmunity." J Clin Invest 1961; 40:1597-1620.
51. Moilan J, Scott E, Dalmasso A. Transfusion reaction with severe thrombocytopenia due to a passively acquired platelet specific antibody. Transfusion 1985;25:459.
52. Aster RH, Keene W. Sites of platelet destruction in idiopathic thrombocytopenic pupura. Br J Haematol 1969;16:61-73.